Cargando…

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage

Podocyte cellular injury and detachment from glomerular capillaries constitute a critical factor contributing to kidney disease. Notably, transcription factors are instrumental in maintaining podocyte differentiation and homeostasis. This study explores the hitherto uninvestigated expression of Nucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshani, Mustafa, Um, In Hwa, Leung, Steve, Reynolds, Paul A., Chapman, Alex, Kudsy, Mary, Harrison, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487238/
https://www.ncbi.nlm.nih.gov/pubmed/37681897
http://dx.doi.org/10.3390/cells12172165
_version_ 1785103192453808128
author Elshani, Mustafa
Um, In Hwa
Leung, Steve
Reynolds, Paul A.
Chapman, Alex
Kudsy, Mary
Harrison, David J.
author_facet Elshani, Mustafa
Um, In Hwa
Leung, Steve
Reynolds, Paul A.
Chapman, Alex
Kudsy, Mary
Harrison, David J.
author_sort Elshani, Mustafa
collection PubMed
description Podocyte cellular injury and detachment from glomerular capillaries constitute a critical factor contributing to kidney disease. Notably, transcription factors are instrumental in maintaining podocyte differentiation and homeostasis. This study explores the hitherto uninvestigated expression of Nuclear Factor Erythroid 2-related Factor 1 (NFE2L1) in podocytes. We evaluated the podocyte expression of NFE2L1, Nuclear Factor Erythroid 2-related Factor 2 (NFE2L2), and NAD(P)H:quinone Oxidoreductase (NQO1) in 127 human glomerular disease biopsies using multiplexed immunofluorescence and image analysis. We found that both NFE2L1 and NQO1 expressions were significantly diminished across all observed renal diseases. Furthermore, we exposed human immortalized podocytes and ex vivo kidney slices to Puromycin Aminonucleoside (PAN) and characterized the NFE2L1 protein isoform expression. PAN treatment led to a reduction in the nuclear expression of NFE2L1 in ex vivo kidney slices and podocytes.
format Online
Article
Text
id pubmed-10487238
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104872382023-09-09 Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage Elshani, Mustafa Um, In Hwa Leung, Steve Reynolds, Paul A. Chapman, Alex Kudsy, Mary Harrison, David J. Cells Article Podocyte cellular injury and detachment from glomerular capillaries constitute a critical factor contributing to kidney disease. Notably, transcription factors are instrumental in maintaining podocyte differentiation and homeostasis. This study explores the hitherto uninvestigated expression of Nuclear Factor Erythroid 2-related Factor 1 (NFE2L1) in podocytes. We evaluated the podocyte expression of NFE2L1, Nuclear Factor Erythroid 2-related Factor 2 (NFE2L2), and NAD(P)H:quinone Oxidoreductase (NQO1) in 127 human glomerular disease biopsies using multiplexed immunofluorescence and image analysis. We found that both NFE2L1 and NQO1 expressions were significantly diminished across all observed renal diseases. Furthermore, we exposed human immortalized podocytes and ex vivo kidney slices to Puromycin Aminonucleoside (PAN) and characterized the NFE2L1 protein isoform expression. PAN treatment led to a reduction in the nuclear expression of NFE2L1 in ex vivo kidney slices and podocytes. MDPI 2023-08-29 /pmc/articles/PMC10487238/ /pubmed/37681897 http://dx.doi.org/10.3390/cells12172165 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Elshani, Mustafa
Um, In Hwa
Leung, Steve
Reynolds, Paul A.
Chapman, Alex
Kudsy, Mary
Harrison, David J.
Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title_full Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title_fullStr Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title_full_unstemmed Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title_short Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
title_sort transcription factor nfe2l1 decreases in glomerulonephropathies after podocyte damage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487238/
https://www.ncbi.nlm.nih.gov/pubmed/37681897
http://dx.doi.org/10.3390/cells12172165
work_keys_str_mv AT elshanimustafa transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT uminhwa transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT leungsteve transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT reynoldspaula transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT chapmanalex transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT kudsymary transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage
AT harrisondavidj transcriptionfactornfe2l1decreasesinglomerulonephropathiesafterpodocytedamage